BILL ANALYSIS
ACR 62
Page 1
Date of Hearing: May 20, 2009
ASSEMBLY COMMITTEE ON APPROPRIATIONS
Kevin De Leon, Chair
ACR 62 (Galgiani) - As Introduced: April 20, 2009
Policy Committee: Health Vote:19-0
Urgency: No State Mandated Local Program:
No Reimbursable:
SUMMARY
This resolution commends the California Department of Health
Care Services (DHCS) for implementing and maintain a disease
management pilot program related to chronic obstructive
pulmonary disease (COPD). In addition this bill:
1)Encourages DHCS to submit interim findings and recommendations
regarding the pilot program to the Legislature.
2)Declares November 2009 as COPD Awareness Month and November
18, 2009 as COPD Awareness Day.
FISCAL EFFECT
Negligible state costs.
COMMENTS
1)Purpose . This bill is sponsored by Boehringer-Ingelheim
Pharmaceuticals, an international company headquartered in
Germany. The company markets several treatments for COPD
including Spiriva, Atrovent, Combinvent, and Duovent. The
commendation in this resolution is in response to a disease
management pilot program administered by DHCS. The pilot
program addresses a number of diseases such as asthma and
diabetes, as well as COPD.
2)COPD is the term for chronic bronchitis, emphysema and a range
of other respiratory disorders. It is a source of significant
health problems in the United States and throughout the world.
Many aspects of COPD are preventable and treatable.
ACR 62
Page 2
Analysis Prepared by : Mary Ader / APPR. / (916) 319-2081